Literature DB >> 10092528

The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses.

M Kohli1, T J Jorgensen.   

Abstract

The simian virus 40 large tumor antigen (SV40 Tag) has been ascribed many functions critical to viral propagation, including binding to the mammalian tumor suppressor p53. Recent studies have demonstrated that SV40-transformed murine cells have functional p53. The status of p53 in SV40-immortalized human cells, however, has not been characterized. We have found that in response to ionizing radiation, p53-dependent p21 transactivation activity is present, albeit reduced, in SV40-immortalized cells and that this activity can be further reduced with either dominant negative p53 expression or higher SV40 Tag expression. Furthermore, overexpression of p53 in SV40-immortalized ataxia-telangiectasia (A-T) cells restores p53-dependent p21 induction to typical A-T levels. All SV40-immortalized cell lines exhibited an absence of G1 arrest. Moreover, all SV40-immortalized cell lines exhibited increased apoptosis relative to primary cells in response to ionizing radiation, suggesting that SV40 immortalization results in a unique phenotype with regard to DNA damage responses. Copyright 1999 Academic Press.

Entities:  

Keywords:  NASA Discipline Radiation Health; Non-NASA Center

Mesh:

Substances:

Year:  1999        PMID: 10092528     DOI: 10.1006/bbrc.1999.0389

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells.

Authors:  E Fritz; A A Friedl; R M Zwacka; F Eckardt-Schupp; M S Meyn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

2.  Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts.

Authors:  Narasimharao Nalabothula; Devulapalli Chakravarty; Adam Pierce; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

3.  Association of ATM activation and DNA repair with induced radioresistance after low-dose irradiation.

Authors:  L Enns; A Rasouli-Nia; M Hendzel; B Marples; M Weinfeld
Journal:  Radiat Prot Dosimetry       Date:  2015-04-22       Impact factor: 0.972

4.  Occurrence of TRGV-BJ hybrid gene in SV40-transformed fibroblast cell lines.

Authors:  L P G D'Arce; C L Bassi; A L Fachin; G A S Passos; E T Sakamoto-Hojo
Journal:  Genetica       Date:  2009-01-14       Impact factor: 1.082

5.  4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells.

Authors:  Abha Sharma; Rajendra Sharma; Pankaj Chaudhary; Rit Vatsyayan; Virginia Pearce; Prince V S Jeyabal; Piotr Zimniak; Sanjay Awasthi; Yogesh C Awasthi
Journal:  Arch Biochem Biophys       Date:  2008-10-07       Impact factor: 4.013

6.  E-cigarettes and health risks: more to the flavor than just the name.

Authors:  M P Ween; A Moshensky; L Thredgold; N A Bastian; R Hamon; A Badiei; P T Nguyen; K Herewane; H Jersmann; C M Bojanowski; J Shin; P N Reynolds; L E Crotty Alexander; S J Hodge
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-12-09       Impact factor: 5.464

7.  Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis.

Authors:  Milica Enoiu; Josef Jiricny; Orlando D Schärer
Journal:  Nucleic Acids Res       Date:  2012-07-18       Impact factor: 16.971

8.  Comparative transcriptome profiling of an SV40-transformed human fibroblast (MRC5CVI) and its untransformed counterpart (MRC-5) in response to UVB irradiation.

Authors:  Cheng-Wei Chang; Chaang-Ray Chen; Chao-Ying Huang; Wun-Yi Shu; Chi-Shiun Chiang; Ji-Hong Hong; Ian C Hsu
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

9.  A safety-modified SV40 Tag developed for human cancer immunotherapy.

Authors:  Stephanie S Tseng-Rogenski; Mohamed S Arredouani; June F Escara-Wilke; Yilin C Neeley; Michael J Imperiale; Martin G Sanda
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.